A useful testing strategy in phase III trials: combined test of superiority and test of equivalence

Journal of Biopharmaceutical Statistics
T Morikawa, M Yoshida

Abstract

A useful testing strategy is proposed for a confirmatory phase III clinical trial. It consists of a combined test of superiority and test of equivalence, and it is easy to apply. By introducing the strategy, we can perform a post hoc analysis in a confirmatory experiment. Thus a more flexible decision will be possible than the usual single testing method provides. It is shown that the procedure needs no adjustment for multiplicity from the point of view of the closed testing procedure. The relationship between this strategy and a confidence interval is also discussed.

Associated Clinical Trials

References

Jan 1, 1991·Journal of Biopharmaceutical Statistics·S D Dubey
Jan 1, 1991·Journal of Biopharmaceutical Statistics·L D Fisher
Jan 1, 1991·Journal of Biopharmaceutical Statistics·J E Overall
Jan 1, 1991·Journal of Biopharmaceutical Statistics·G G Koch

❮ Previous
Next ❯

Citations

Sep 27, 2001·Advances in Therapy·S GandolfiUNKNOWN Bimatoprost Study Group 3
Oct 14, 2000·European Journal of Drug Metabolism and Pharmacokinetics·V W SteinijansF Bretz
Oct 3, 2006·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·John UpchurchRoger Echols
Mar 16, 2004·Survey of Ophthalmology·Thomas R WaltersUNKNOWN Bimatoprost Circadian IOP Study Group
Jun 23, 2001·The New England Journal of Medicine·E J TopolUNKNOWN TARGET Investigators. Do Tirofiban and ReoPro Give Similar Efficacy Trial
Aug 21, 2009·The New England Journal of Medicine·Tony S MokMasahiro Fukuoka
Mar 12, 2010·The New England Journal of Medicine·Olivier ChosidowIan Burgess
Nov 11, 2005·Journal of Biopharmaceutical Statistics·Tatsuki Koyama, Peter H Westfall
Mar 17, 2007·Journal of Biopharmaceutical Statistics·H M James HungRobert O'Neill
Mar 17, 2007·Journal of Biopharmaceutical Statistics·Yi Tsong, Wen-Jen Chen
Mar 17, 2007·Journal of Biopharmaceutical Statistics·Yi Tsong, Joanne Zhang
Mar 17, 2007·Journal of Biopharmaceutical Statistics·Tie-Hua Ng
Nov 21, 2007·Journal of Biopharmaceutical Statistics·Christopher Jennison, Bruce W Turnbull
Dec 29, 2007·Journal of Biopharmaceutical Statistics·Gene Pennello, Laura Thompson
Jan 8, 2009·Journal of Biopharmaceutical Statistics·H M James Hung, Sue-Jane Wang
Nov 7, 2007·Transplantation·Helio Tedesco-SilvaUNKNOWN FTY720 2218 Clinical Study Group
Mar 1, 1997·Annals of Periodontology·G G Koch, D W Paquette
Feb 20, 2002·Controlled Clinical Trials·Brian L Wiens
Oct 17, 2013·Journal of Veterinary Internal Medicine·K J FreiseT P Clark
Nov 26, 2015·Pharmaceutical Statistics·Laura Flight, Steven A Julious
Feb 21, 2009·Journal of the American College of Surgeons·Ernest E MooreUNKNOWN PolyHeme Study Group
Jan 7, 2006·Biometrical Journal. Biometrische Zeitschrift·Yi Tsong, Juan Joanne Zhang
Sep 29, 2005·Statistics in Medicine·Steven A Julious
Feb 15, 2003·Statistics in Medicine·Andrew D Garrett
Sep 16, 2003·Statistics in Medicine·Ying LuHarry K Genant
May 4, 2007·Statistics in Medicine·David Edwards, Jesper Madsen
Dec 29, 2005·Statistics in Medicine·Larry L LasterMitchell L Kotler
Jul 1, 2010·Biometrical Journal. Biometrische Zeitschrift·H M James Hung, Sue-Jane Wang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.